Amyotrophic Lateral Sclerosis Report Cover TrendFeedr

Amyotrophic Lateral Sclerosis Report

: Analysis on the Market, Trends, and Technologies
Topic Size
trending indicator
Topic Maturity
Monthly Search Volume

The business domain of amyotrophic lateral sclerosis (ALS) encompasses a multifaceted ecosystem involving R&D, healthcare, biotechnology, and pharmaceuticals sectors. The data reflects a robust engagement of 847 companies, indicating a substantial scope for growth and innovation in addressing this serious neurological disorder. With a notable $15.52 billion in funding, the industry demonstrates a stable foundation for advancements and research, despite fluctuations in growth and media coverage. The surge in interest and investment in related medical disciplines underscores a growing focus on improving treatment options and patient care for neurological disorders.

This report was last updated 5 days ago. Spot an error or missing detail? Help us fix it by getting in touch!

Topic Dominance Index of Amyotrophic Lateral Sclerosis To identify the Dominance Index of Amyotrophic Lateral Sclerosis in the Trend and Technology ecosystem, we look at 3 different time series: the timeline of published articles, founded companies, and global search. These timelines are normalized and combined to show a comprehensive view of the Amyotrophic Lateral Sclerosis evolution relative to all known Trends and Technologies.

Dominance Index growth in the last 5 years: 70.67%
Growth per month: 0.8939%

Key Activities and Applications

  • Clinical stage development of biologic treatments for neurological diseases and wound healing.
  • Health information provision, including community forums and support groups.
  • Drug development targeting brain and nervous system diseases with a focus on zinc and nerve cell regeneration.
  • Therapeutic and prophylactic treatments for neurological diseases like Parkinson's and multiple sclerosis.
  • Commercialization and development of diagnostics and therapeutics for growth hormone deficiency and other conditions.
  • Pharmaceutical and chemical company innovation targeting improved patient health and quality of life.
  • Support and management services for patients and families coping with illnesses and injuries.
  • Collaborative community and assistive technology hub for people with disabilities.
  • Development of nerve stem cell technology for spinal cord injury treatment.
  • Sport science and performance tools integration for goal achievement.

Technologies and Methodologies

  • Biologic treatments leveraging genetically engineered proteins.
  • Strategic research approaches in drug development.
  • Innovative prophylactic and therapeutic treatments using stochastic resonance.
  • First and only approved oral tests for adult growth hormone deficiency diagnosis.
  • Next-generation software solutions for computer accessibility.
  • Non-viral gene therapy platforms for immune modulation.
  • Computational drug discovery and early-stage drug validation tools.

Amyotrophic Lateral Sclerosis Funding

A total of 227 Amyotrophic Lateral Sclerosis companies have received funding.
Overall, Amyotrophic Lateral Sclerosis companies have raised $15.9B.
Companies within the Amyotrophic Lateral Sclerosis domain have secured capital from 721 funding rounds.

The chart shows the funding trendline of Amyotrophic Lateral Sclerosis companies over the last 5 years

Funding growth in the last 5 years: 55.28%
Growth per month: 0.7608%

Amyotrophic Lateral Sclerosis Companies

The Companies feature is a crucial part of TrendFeedr. It offers in-depth information about 780 companies working within Amyotrophic Lateral Sclerosis and other trends and technologies. Identify and analyze innovators and key players in relevant industries more easily with this feature.

companies image

780 Amyotrophic Lateral Sclerosis Companies

Discover Amyotrophic Lateral Sclerosis Companies, their Funding, Manpower, Revenues, Stages, and much more

View all Companies

Amyotrophic Lateral Sclerosis Investors

TrendFeedr’s investors tool offers a detailed view of investment activities that align with specific trends and technologies. This tool features comprehensive data on 254 Amyotrophic Lateral Sclerosis investors, funding rounds, and investment trends, providing an overview of market dynamics.

investors image

254 Amyotrophic Lateral Sclerosis Investors

Discover Amyotrophic Lateral Sclerosis Investors, Funding Rounds, Invested Amounts, and Funding Growth

View all Investors

Amyotrophic Lateral Sclerosis News

Stay informed and ahead of the curve with TrendFeedr’s News feature, which provides access to 5.2K Amyotrophic Lateral Sclerosis articles. The tool is tailored for professionals seeking to understand the historical trajectory and current momentum of changing market trends.

articles image

5.2K Amyotrophic Lateral Sclerosis News Articles

Discover Latest Amyotrophic Lateral Sclerosis Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications

View all Articles

Executive Summary

The ALS business domain is characterized by dynamic growth and resilience, with companies engaging in groundbreaking research and patient-centered innovations. The industry's commitment to advancing medical care is evident through substantial investments and the development of novel treatments aimed at neurological disorders. As the sector continues to evolve, it maintains a strong focus on improving patient outcomes and exploring new frontiers in biotechnology and healthcare.

Interested in enhancing our coverage of trends and tech? We value insights from experts like you - reach out!

StartUs Insights logo

Discover our Free Healthcare Trends Report

Discover emerging Healthcare Trends!
We'll deliver our free report straight to your inbox!

    Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Spot Emerging Trends Before Others

    Get access to the full database of 20,000 trends

      Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

        Let's talk!

          Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.